Atlas Trials

Evaluation of the Persistence of the Complete Molecular Remission After Stopping Imatinib Chronic Myeloid Leukemia

Clinical trial NCT00478985 · COMPLETED

Trial details

NCT number
NCT00478985
Sponsor
University Hospital, Bordeaux
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Myeloid Leukemia, Chronic
Start date
2007-06-01
Primary completion
2011-12-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.